DDAH2 Recombinant Antibody

$Lane 1: Rat Heart; Lane 2: Mouse Heart; Lane 3: Mouse Lung; Lane 4: Human Lung; Probed with DDAH2 (1C11) Monoclonal Antibody (bsm-54287R) at 1:2000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.$

Lane 1: Rat Heart; Lane 2: Mouse Heart; Lane 3: Mouse Lung; Lane 4: Human Lung; Probed with DDAH2 (1C11) Monoclonal Antibody (bsm-54287R) at 1:2000 overnight at 4\u00b0C followed by a conjugated secondary antibody for 60 minutes at 37\u00b0C.

Applications

Reactivity

Human

Predicted Reactivity

Mouse
Rat

Overview
Catalog #	bsm-54287r
Product Name	DDAH2 Recombinant Antibody
Applications	WB
Reactivity	Human
Predicted Reactivity	Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	Synthetic peptide within Human DDAH2 aa 1-100
Clonality	Recombinant
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	23564
Swiss Prot	O95865
Subcellular location	Cytoplasm, Mitochondrion
Synonyms	N(G) N(G)-dimethylarginine dimethylaminohydrolase 2; DDAHII; Dimethylargininase-2; Protein G6a; S-phase protein; DDAH-2; Dimethylarginine dimethylaminohydrolase 2; DDAH2; DDAH; G6A; NG30
Background	Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. Has therefore a role in the regulation of nitric oxide generation.
Application Dilution
WB	1:300-5000